Member Info for Uncanny

Who is buying EHGO’s stock? No way it is PI’s as we simply haven’t had enough buying volume go through IMHO, plus MM will not want them the shares on their book by end of each day business close. Where are they going?

ValiRx outlines next step for prostate cancer drug Share 07:42 29 May 2019 VAL201 has been shown to be safe and well tolerated during phase I/II trials and, crucially, there was “primary evidence” of the drug’s activity in patients drugs being tested The company has been conducting early-stage clinical trials of its lead drug ValiRx Plc (LON:VAL) said the dose ranging study of its lead drug continued as it outlined potential next steps. VAL201 is being used to treat men with prostate cancer drug. It is also being developed to combat hormone-induced unregulated growth including endometriosis. It has been shown to be safe and well tolerated during phase I/II trials and, crucially, there was “primary evidence” of the drug’s activity in prostate cancer. The company has said previously that results from the trial are expected at the end of the first-half, which will be followed by data analysis and the publication of the full findings of the clinical assessment. In an update alongside its full-year results, ValiRx also said it would either out-licence VAL201 to a major pharmaceutical company or proceed to a phase llb study once dose-ranging is complete.

You mean selling in an entity down from .55 to .23 and getting your investment back, yet at the same time buying the shares back through a different entity and getting a good average entry price before ground breaking news? Nothing wrong with that. Makes you think how easy they managed to sell down so quickly, offloading probably close to 71mn shares?!

From Shares Magazine: “....... if an investor is looking at an entry point to a company, a large share overhang may be good news if it leads to some short-term weakness in the share price. Once the market has digested the available shares, chances are that the price may start its upward descent again.”

Didn't realise about the director share options - 17.3 mn shares at 4p is £692,000.

Noise, see what you mean..... geez! Xtandi (enzalutamide) is an androgen receptor inhibitor indicated for the treatment of prostate cancer in patients who have previously received Docefrez (docetaxel). Side effects of Xtandi include: seizures, back pain, diarrhea, joint or muscle pain, hot flashes, flushing (warmth, redness, or hot feeling), headache, muscle weakness or stiffness, anxiety, dizziness, sleep problems (insomnia), feeling tired, numbness/burning pain/tingling/prickly feeling under your skin, swelling in your hands or feet, cold symptoms (such as stuffy nose, sneezing, and sore throat), high blood pressure, upper respiratory tract infection, blood in the urine, urinary frequency, dry skin, itching, or nosebleeds.

Gimmeshelter The 9.03 was a rollover, maybe Bed & ISA - sale at .2 and buy back at .2015

True 30% on 4mg so where would the optimum dose be between 4mg and 16mg? and what PSA reduction? Can we get to 50% like JnJ Zytiga and without the side effects, including arch rival Xtandi (enzalutamide) from Pfizer? “Zytiga is still romping away, with a 40% gain in the year to $3.5 billion” “Pfizer has said that the drug would reach over $1 billion in U.S. annual sales by 2020“

Yep Rightback and you know what traditionally happens when a stock overhang clears!?

Isn’t that 2500% Noise? Logan, l also bought more this morning.

I presume as soon as the new deal is agreed with ABO, we will then get the AGM date. Rightback, l am sure there will be positives to spill the beans on before AGM to line us all up. Last day of 201 trials tomorrow.

Great, lets get the stock overhang gone and then hopefully coiled spring, plus 201 and 401 news by end of year!

Who are we talking about?

A few bottom fishers or averaging down plus a roll over or bed and ISA this morning of 2.5mn.

Pi’s really? Think about it.

But you miss a HUGE whole! Who is buying them and why?

Depends on your average l guess? Is it going to go pop or pop with good news?

Valju, can you just imagine if VAL get a monster deal? The science works and YES, they are in overdraft until it happens! I remember being underwater in my field of work, but with perseverance and investment it came good. Whats different here apart from a bit patience?

What a ridiculous post January! EHGO caused the falling SP to get their money back. I bet VAL are completely fxxxxd off and thats why they cancelled the facility. I would, wouldn’t you? They have four great compounds to sell (and more in the pipeline) they work and commercial.

TH - hope you are right in a positive way for suffering SH’s! VAL always RNS’d good news to soak up placings as we know, this time we have the opposite - good news after bad / indifferent? Things getting interesting.